Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.
D. Reardon, K. Fink, T. Mikkelsen, T. Cloughesy +14 more
2008Journal of Clinical Oncology480 citations Open access
Semantic Scholar

